Semax is a synthetic ACTH(4-10)-derived heptapeptide investigated in neuroscience and cellular-stress research models. The original overview of this page asks three questions: ACTH-derived sequence design, the neuroscience models in which the analogue has been studied, and sequence identity, purity, and handling documentation for the lot on the bench.
Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about a Velnacor lot and are not instructions for use in people or animals.
ACTH-derived sequence design
Dolotov and colleagues identified Semax as the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, an analogue of the adrenocorticotropin fragment ACTH(4-10) (Dolotov et al., 2006). Eremin and colleagues used the same sequence description (Met-Glu-His-Phe-Pro-Gly-Pro) in a rodent neurochemistry study (Eremin et al., 2005). That sequence language should appear consistently on the brief, the quotation, and the report. Semax is not unmodified ACTH, and it is not an interchangeable “ACTH fragment” label for a neighboring analogue such as Selank.
Neuroscience model findings
In rat hippocampus, Dolotov and colleagues reported that a single application of Semax increased BDNF protein, trkB tyrosine phosphorylation, and selected BDNF and trkB mRNA measures, and that treated animals showed an increase in conditioned avoidance reactions (Dolotov et al., 2006). The authors suggested that Semax may affect cognitive functions in that model by modulating the hippocampal BDNF/trkB system. That is a finding in the rat design they described. It is not a demonstration of a clinical outcome, and it is not a use instruction.
Eremin and colleagues reported that Semax increased striatal 5-HIAA tissue content and extracellular 5-HIAA in rodents, did not by itself alter dopamine or dopamine-metabolite concentrations in the measures they reported, and, when given before D-amphetamine, enhanced amphetamine’s effects on extracellular dopamine and on locomotor activity (Eremin et al., 2005). Those are rodent neurochemical and behavioral observations. They should not be transferred automatically to another species or to a different peptide in the same catalog family.
The title of the Eremin paper describes Semax as an ACTH(4-10) analogue “with nootropic properties.” That phrasing belongs to the authors of that article. This page does not adopt it as a product, cognitive, or clinical claim, and it is not a reason to treat Semax as interchangeable with Selank or with unmodified ACTH fragments.
Identity, purity, and handling records
A useful quality review still separates sequence identity, purity, content, and lot matching. Handling and storage notes belong in the receiving file; this page does not provide a laboratory procedure. What Is a Peptide COA?, How to Read a Peptide COA, Third-Party Peptide Testing, Explained, HPLC vs Mass Spectrometry for Peptide Lot Review, and lot traceability apply to this material as to other research peptides. Transit and arrival records, where relevant, are discussed in Cold-Chain Records for Lyophilized Research Peptides.
Semax appears in Velnacor’s research-material catalog (internal product record, slug semax), as does a combination SKU with Selank. There is not a standalone public landing page for every catalog name; use the product directory and the COA Library, then confirm the exact SKU and current-lot documents in the inquiry. For packing at supply scale, see wholesale peptides. Combination presentations, if purchased, need their own identifiers and should not borrow a Semax-only report.
Selected published literature
- Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, Dubynina EV, Novosadova EV, Andreeva LA, Alfeeva LY, Kamensky AA, Grivennikov IA, Myasoedov NF, Engele J. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research. 2006;1117(1):54-60. doi:10.1016/j.brainres.2006.07.108. PubMed 16996037.
- Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochemical Research. 2005;30(12):1493-1500. doi:10.1007/s11064-005-8826-8. PubMed 16362768.
Sourcing notes for qualified buyers
Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.
Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.
Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.